全球肺标记市场

According to the latest report by IMARC Group, titled“肺标记市场：全球行业趋势，份额，规模，增长，机会和预测2020-2025，”theglobal lung marker market在2014 - 2019年期间，尺寸的复合年增长率约为8％。肺标记是由用于肺定位的肿瘤细胞产生的物质。它们是根据癌症在体内产生的，在患者的尿液，血液和粪便中发现。它们在肺部干预程序中用于提供有关癌症性质和状况的信息。它们还有助于诊断，预测和监测肿瘤，以了解治疗疾病所需的治疗类型。除此之外，它们还用于众多医院和其他医疗机构，用于诊断和治疗胸膜积液和间皮瘤。

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

全球肺标记市场Trends:

The global market is primarily driven by the increasing prevalence of lung cancer and the high mortality rates associated with it. This has led the key players to heavily invest in research and development (R&D) for the introduction of an effective cure. Since lung markers form an indispensable component in lung localization, a significant increase in their demand has been registered. Along with this, there has been an increase in the occurrence of respiratory disorders on account of deteriorating air quality, unhealthy lifestyle preferences and high smoking rates among the masses. Furthermore, the growing geriatric population across the globe is vulnerable to develop acute respiratory disorders, which is propelling the demand for lung markers. Governments of several countries are also offering numerous healthcare benefits for the early diagnosis and pre-treatment of several chronic diseases, such as lung cancer, which is acting as another major growth-inducing factor. On account of the aforementioned factors, the market is expected to exhibit strong growth during the forecast period (2020-2025).

市场摘要：

• On the basis of the cancer type, the market has been bifurcated into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
• Based on the marker type, the market has been divided into EGFR, EML4-ALK, KRAS, BRAF and others.
• 在最终用户的基础上，市场已分为医院，诊断实验室等。
• On the geographical front, the market has been segregated into North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Latin America (Brazil, Mexico, Argentina, Columbia, Chile, Peru and others), and Middle East and Africa (Turkey, Iran and others).
• The competitive landscape of the market has been analyzed in the report with the detailed profiles of the key players operating in the market. Some of these players include Abbott Laboratories, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Beckman Coulter, Inc., Fujirebio Europe N.V., Hologic, Inc., F. Hoffmann-La Roche Ltd, Siemens Healthineers, and BioSpace, Inc.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC的信息产品包括针对制药，工业和高科技组织的商业领导者的主要市场，科学，经济和技术发展。对生物技术，高级材料，药品，食品和旅游，旅行和旅游，纳米技术和新颖加工方法的市场预测和行业分析是公司专业知识的首位。

联系我们

欧宝电竞首页
美国： +1-631-791-1145
Email: sales@imarcgroup.com
网站：https：//www.cflgrp.com
Follow us on twitter: @imarcglobal